Equine IL-4, Unconjugated from R&D Systems

Navigation Links

Biology News Medicine News Biology Products Medicine Products Biology Definition Medicine Definition Biology Technology Medicine Technology Biology Dictionary Medicine Dictionary

HOME >> BIOLOGY >> PRODUCTS

Equine IL-4, Unconjugated from R&D Systems

Products	Equine IL-4, Unconjugated from R&D Systems
Company	R&D Systems
Item	Equine IL-4, Unconjugated
Price	$330.00
Description	Recombinant Equine IL-4, CF
Info	R&D Systems R&D Systems, Inc. 614 McKinley Place N.E. Minneapolis, MN 55413 Customer Service: 1 (800) 343-7475 1 (612) 379-2956 Fax Number: 1 (612) 656-4400 Web Site: http://www.rndsystems.com

NOTE: Price information is approximate list price and actual prices may vary.

Related biology products :

1. Equine TNF alpha ELISA development Kit, Screening Set from Endogen
2. Equine TNF ALPHA from AbD Serotec
3. Equine IL-4 from AbD Serotec
4. Equine TNF-alpha (TNFSF1A) ELISA development Kit, DuoSet from R&D Systems
5. Equine TNF-alpha / TNFSF1A, Unconjugated from R&D Systems
6. Equine IL-6, Unconjugated from R&D Systems
7. Equine Immunoglobulin G from Equitech-Bio
8. Donor Equine Serum from Equitech-Bio
9. Mouse Anti-Amodiaquine Monoclonal Antibody, Unconjugated, Clone 6D10 from AntibodyShop A/S
10. Mouse Anti-Protein S Monoclonal Antibody, Unconjugated, Clone HYB 232-02 from Abcam
11. Mouse Anti-Mouse Glutathione S-transferase M1 (GSTM1) Monoclonal Antibody, Unconjugated from Lifespan Biosciences

TAG: Equine Unconjugated from Systems

Biology Products:

Microsart e.motion Membrane Filters from Sartorius AG PCR Workstation (240 V) from Sigma-Aldrich DNeasy Plant Mini Kit (250) from QIAGEN Antibody MicroArray from Lab Vision

Breaking Biology News(10 mins):BIO-key(R) Shareholders Overwhelmingly Approve Sale of Law Enforcement Division 2 BIO-key(R) Shareholders Overwhelmingly Approve Sale of Law Enforcement Division 3 A window that washes itself? 2 VAI researchers find long awaited key to creating drought resistant crops 2 VAI researchers find long awaited key to creating drought resistant crops 3 Bringing harmony to electronic waste disposal 56281 1 Bringing harmony to electronic waste disposal 56281 2 LSU receives 243 6 million to fund center studying hazardous waste cleanup and health impacts 9799 1 LSU receives 243 6 million to fund center studying hazardous waste cleanup and health impacts 9799 2 Biophysical Society Announces 2010 society fellows 9794 1

[1] BIO-key(R) Shareholders Overwhelmingly Approve Sale of Law Enforcement Division [0] A window that washes itself?[0] VAI researchers find long awaited key to creating drought resistant crops

Other Biology News:New whale detection buoys will help ships take the right way through marine habitat 2 New whale detection buoys will help ships take the right way through marine habitat 3 New species discovered in Brazil 2 Scientists determine drug target for the most potent botulinum neurotoxin 2

New whale detection buoys will help ships take the right way through marine habitat New species discovered in Brazil Scientists determine drug target for the most potent botulinum neurotoxin

Breaking Biology Technology:Merrimack Pharmaceuticals Acquires Hermes Biosciences, Inc. 2 Merrimack Pharmaceuticals Acquires Hermes Biosciences, Inc. 3 RE-COVER Study Evaluating Dabigatran Etexilate Met Primary Outcome for the Six-Month Treatment of Patients with Acute Venous Thromboembolism (VTE) 2 RE-COVER Study Evaluating Dabigatran Etexilate Met Primary Outcome for the Six-Month Treatment of Patients with Acute Venous Thromboembolism (VTE) 3 RE-COVER Study Evaluating Dabigatran Etexilate Met Primary Outcome for the Six-Month Treatment of Patients with Acute Venous Thromboembolism (VTE) 4 RE-COVER Study Evaluating Dabigatran Etexilate Met Primary Outcome for the Six-Month Treatment of Patients with Acute Venous Thromboembolism (VTE) 5 RE-COVER Study Evaluating Dabigatran Etexilate Met Primary Outcome for the Six-Month Treatment of Patients with Acute Venous Thromboembolism (VTE) 6 Stemline Therapeutics Announces Poster Presenting in vivo and Anti-Cancer Stem Cell Activity of SL-401 against Chronic Myeloid Leukemia (CML) at the 51st Annual Meeting of the American Society of Hematology (ASH) 2 Access Pharmaceuticals Provides Update on MuGard Commercial Launch in Europe 2 Access Pharmaceuticals Provides Update on MuGard Commercial Launch in Europe 3 Access Pharmaceuticals Provides Update on MuGard Commercial Launch in Europe 4

[0] Merrimack Pharmaceuticals Acquires Hermes Biosciences, Inc. [0] RE-COVER Study Evaluating Dabigatran Etexilate Met Primary Outcome for the Six-Month Treatment of Patients with Acute Venous Thromboembolism (VTE)[0] Stemline Therapeutics Announces Poster Presenting in vivo and Anti-Cancer Stem Cell Activity of SL-401 against Chronic Myeloid Leukemia (CML) at the 51st Annual Meeting of the American Society of Hematology (ASH)[0] Access Pharmaceuticals Provides Update on MuGard Commercial Launch in Europe